Investors

We refer to the announcements dated 28 October 2015, 24 November 2015 and 3 December 2015 in relation to the Sukuk Programme of XL (“Announcements”). Unless otherwise stated, the definitions used herein shall have the same meanings as set out in the Announcements.

We are pleased to announce that XL, a subsidiary of Axiata, had on 2 May 2017 issued and listed on the IDX Tranche II of the Sukuk Programme amounting to IDR2.18 trillion. The details of the Tranche II Sukuk are as follows:-

The Tranche II Sukuk has with effect from today, been listed and quoted on the IDX under the above-mentioned ISIN Codes.

Notes:

(1) Equivalent to approximately RM338,000,000, based on middle rate of IDR100:RM0.0325 as at 12.00 noon on 2 May 2017 as published by Bank Negara Malaysia (“Rate”)

(2) Equivalent to approximately RM130,650,000, based on the Rate.

(3) Equivalent to approximately RM46,150,000, based on the Rate.

(4) Equivalent to approximately RM84,500,000, based on the Rate.

(5) Equivalent to approximately RM109,200,000, based on the Rate.

This announcement is dated 2 May 2017.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities in Malaysia, the United States or any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No securities may be offered or sold in the United States absent registration or an applicable exemption from registration requirements. Any public offering of such securities to be made in the United States will be made by means of a prospectus. Such prospectus will contain detailed information about the company making the offer and its management and financial statements. No public offer of securities is to be made by Axiata or XL in the United States.

No approval from the Securities Commission of Malaysia (“SC”) is or will be obtained under the Capital Markets and Services Act 2007 (“CMSA”) in respect of the securities, and no prospectus which complies with the requirements of the CMSA and the guidelines of the SC has been registered with the SC pursuant to the CMSA or with any other regulatory body in Malaysia. No securities may be offered or sold to any person in Malaysia, except to a person falling within paragraphs 7, 8, 9, 11, 12, 13 or 14 of Schedule 6 of the CMSA, or any other persons as may be specified by the SC in any guideline issued under Section 377 of the CMSA, by a holder of a Capital Markets Services Licence who carries on the business of dealing in securities.